Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;100(10):1867-76.
doi: 10.2105/AJPH.2009.184796. Epub 2010 Aug 19.

Antiretroviral therapy as HIV prevention: status and prospects

Affiliations

Antiretroviral therapy as HIV prevention: status and prospects

Kenneth H Mayer et al. Am J Public Health. 2010 Oct.

Abstract

As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of antiretroviral HIV prevention, including chemoprophylaxis, as well as the effects of treatment of infected individuals on prevention. It is possible that the life-saving agents that have transformed the natural history of AIDS can be a critical component of HIV prevention efforts, but their ultimate role in affecting HIV transmission dynamics remains to be defined.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Potential approaches to prevent HIV transmission. Note. HAART = highly active antiretroviral therapy; PEP = postexposure prophylaxis; PrEP = preexposure prophylaxis; STI = sexually transmitted infection. Bolded items are those that use antiretroviral agents.
FIGURE 2
FIGURE 2
Potential effects of highly active antiretroviral therapy on HIV transmission. Note. HAART = highly active antiretroviral therapy; STI = sexually transmitted infection.

Comment in

References

    1. UNAIDS 2008 update on the global AIDS epidemic. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008j. Accessed June 1, 2009
    1. Markel H. The search for effective HIV vaccines. N Engl J Med. 2005;353(8):753–757 - PubMed
    1. Johnston MI, Fauci AS. An HIV vaccine—evolving concepts. N Engl J Med. 2007;356(20):2073–2081 - PubMed
    1. Klasse PJ, Shattock R, Moore JP. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med. 2008;59:455–471 - PubMed
    1. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–29 - PubMed

Publication types

Substances